MBP and myeloid sarcoma: Another example of the cross-reactivity phenomenon is that T cell clones from MS patients recognize the immunodominant myelin basic protein (MBP)89–101 peptide bound to human leukocyte antigen (HLA)-DR2, which is associated with MS susceptibility (Li et al., 2005).